Analyst Lee Lueder works at DEUTSCHE BANK and is focused on the Healthcare sector with 18 price targets and ratings documented since 2020 spanning on 2 stocks. Analyst's average stock valuation to be materialised ratio is 77.5% with an average time for price targets to be met of 64 days.
Most recent stock forecast was given on CRL, Charles River Laboratories International, Inc at 16-Nov-2021.
Lee Lueder best performing recommendations are on CTLT (CATALENT, INC).
The best stock recommendation documented was for CTLT (CATALENT, INC) at 2/11/2021. The price target of $120 was fulfilled within 7 days with a profit of $3 (2.44%) receiving and performance score of 3.48.
Average potential price target upside
Currently, out of the existing stock ratings of Lee Lueder - 657 which are a Buy (47.99%), 712 which are a Hold (52.01%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
203
$4.97 (2.51%)
3 days ago
27/30 (90%)
$21.78 (18.53%)
193
Buy
260
$61.97 (31.29%)
280
1 months 8 days ago
2/6 (33.33%)
$49.05 (19.94%)
89
Hold
230
$31.97 (16.14%)
241
1 months 8 days ago
15/20 (75%)
$35.42 (11.94%)
92
Buy
285
$86.97 (43.92%)
461
2 months 20 days ago
5/7 (71.43%)
$27.82 (11.71%)
96
Buy
260
$61.97 (31.29%)
400
3 months 30 days ago
6/8 (75%)
$24.13 (12.73%)
85
